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ABSTRACT  
 
Purpose: To develop and evaluate a rapid 3D quantitative T2 mapping method for prostate 
cancer imaging using Dual Echo Steady State (DESS) MRI at 3T.  
Methods: In simulations, DESS-T2 mapping in the presence of T1 and B1+ variations was 
evaluated. In a phantom and healthy volunteers (n = 4), 3D DESS-T2 mapping was 
compared to a 2D turbo spin echo (TSE) approach. In volunteers and a pilot patient study 
(n = 29), quantitative T2 in normal prostate anatomical zones and in suspected cancerous 
lesions was evaluated.  
Results: The simulated bias for DESS-T2 was less than 2% (5%) for typically observed T1 
(B1+) variations. In phantoms and in vivo, high correlation of DESS-T2 and TSE-T2  (r2 = 
0.98 and 0.88, p-value < 0.001) was found. DESS-T2 in the normal peripheral zone (PZ) / 
transition zone (TZ) was 115 ± 26 ms / 64 ± 7 ms in healthy volunteers and 129 ± 39 ms / 
83 ± 12 ms in patients. In suspected cancerous lesions, DESS-T2 was 72 ± 14 ms, which 
was significantly decreased from normal PZ (p < 0.001), but not from TZ. 
Conclusion: Rapid 3D T2 mapping in the entire prostate can be performed in one minute 
using DESS.  
 
Keywords: Prostate Cancer Imaging, T2 mapping, Dual Echo Steady State (DESS) MRI, 
and 3T MRI. 
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INTRODUCTION 
Prostate cancer is the second leading cause of cancer related death in men in the U.S. (1).  
Conventionally, prostate cancer is diagnosed and monitored using transrectal 
ultrasonography (TRUS)-guided systematic needle biopsy to obtain tissue samples, which 
are assigned a Gleason Score (GS) indicating the aggressiveness of cancer. However, due 
to sampling bias this approach might miss clinically significant cancer and it is an 
uncomfortable, invasive procedure that some patients undergo repeatedly in conventional 
active surveillance. Magnetic Resonance Imaging (MRI) is a promising, non-invasive 
tool to detect and monitor prostate cancer (2). Prostate MRI relies on multi-parametric 
(mp) T2-weighted (w), diffusion and dynamic contrast-enhanced imaging. However, 
qualitative analysis of mp-MRI alone performs suboptimally in distinguishing indolent 
from aggressive cancers. Le et al found that ~30% of clinically significant tumors (GS > 
7 on whole-mount histopathology) were missed by multi-parametric MRI (mp-MRI) (3).  
Therefore, systematic biopsy is still considered the gold standard for assessing prostate 
cancer aggressiveness (4).  
Quantitative MRI has shown promise for assessing tumor aggressiveness (5–9). Further, 
quantitative as opposed to qualitative MRI can reduce subjectivity in the assessment, 
which is important for long-term monitoring of patients such as men on active 
surveillance, as well as to improve uniformity of reporting across readers and institutions. 
However, the implementation of quantitative methods is technically challenging and thus 
far limited to research settings. One quantitative MR parameter, T2 relaxation, reflects the 
interaction of water molecules on a cellular level and is therefore potentially highly 
sensitive to detect pathological tissue alterations. However, current methods to reliably 
measure T2, such as single spin-echo (SE), acquire multiple image sets to map T2. This 
results in compromises between spatial resolution, 3D coverage, and scan time. The 
impractically long scan times associated with SE-T2 mapping, which might be on the 
order of tens of minutes, also make scans highly vulnerable to motion artifacts. Further, 
extracting T2 from multi-contrast images is limited in accuracy due to potential mis-
registration between images. Multi-echo SE sequences, such as turbo spin echo (TSE), 
are commonly used to speed up the acquisition. However, quantification is limited 
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because of contributions of stimulated and indirect echoes to the multi-echo signal, which 
depends on a variety of parameters including T2, T1, B0, B1+ and diffusion. The accuracy 
of TSE-T2 mapping can be improved by using a more complicated fitting approach, 
which accounts for all above-mentioned echo contribution effects, e.g. stepwise Bloch 
simulations, but this requires the pre-computation of a signal data base for fitting (10). 
Alternatively, three-dimensional (3D) dual echo steady state (DESS) MRI (11–13) has 
shown its potential for T2-mapping in the knee (14–16). DESS acquires two images 
(“FID” and “Echo”) with distinct contrast in a single scan. This feature of DESS allows 
for both morphological T2-weighted (T2-w) and quantitative T2 imaging in a single scan. 
Even though a simple exponential fit can yield quantitative T2 if a flip angle (FA) of 90o 
is used, to achieve sufficient SNR, DESS is typically performed at lower FA. As a 
consequence, T2 mapping requires detailed modeling of the DESS signals (14–18).  
We propose the application of DESS to achieve rapid 3D T2 maps of the entire prostate. 
In this work, we aim to evaluate quantitative T2 mapping with 3D DESS applied to the 
prostate in simulations, phantoms, healthy volunteers and a pilot patient study.  
  
METHODS 
This research was approved by the local institutional review board and all human subjects 
gave written, informed consent prior to scanning. MRI experiments were performed on a 
3T MRI system (TIM Trio or Skyra, Siemens Healthcare, Erlangen, Germany) using a 
body matrix and a spine array coil. DESS was acquired in addition to standard T2 
mapping reference sequences (TSE in volunteers) and in addition to standard clinical 
sequences for prostate mp-MRI (in patients).  
DESS Acquisition and T2 Mapping 
The DESS sequence is a steady-state free precession (SSFP) sequence, which acquires 
two signals in each TR: 1) “FID” with mixed T2 /T1 contrast and 2) “Echo” with 
primarily T2 contrast (Figure 1). The ratio of these two signals was fitted to a signal 
model to obtain quantitative T2 values for each image voxel (17). Detailed sequence 
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parameters are listed in Table 1. Quantitative T2 mapping was performed in MATLAB 
R2013b (MathWorks, Natwick, MA, USA).  
The signal ratio of DESS Echo and FID (S) shows a strong T2 dependence (14–17,19), 
which is used to fit quantitative T2. Since it also depends on T1 and B1+, these parameters 
need either be measured to be included on a per voxel basis in the data fitting algorithm, 
or, in a simplified approach, a global (fixed) estimate for T1 and B1+ can be used (16): 
 𝑇!,!"# = argmin!!∈!!,!"#$% 𝑆!"#$ 𝑇!,𝐵!!,𝑇! − 𝑆 𝑇!,!"#,𝐵!,!"#! ,𝑇! ! ( 1 ) 
 
Where Smeas(T1,B+1,T2) is the measured signal ratio and S(T1,fix,B+1,fix,T2) are calculated 
from the signal model for each candidate T2 in a predetermined range (T2,range).  
 
Simulations 
In simulations, we sought to quantify the bias of fitted T2 with respect to T1 and B1+, if 
these were implemented as a fixed global estimate in a parameter range typically 
observed in prostate MRI. For the global estimate, we used T1, fix = 2200 ms based on a 
recent study, which measured average T1 in the prostate in 108 patients (20). We set 
relative B1+,fix = 1. Simulations were performed over a physiologically relevant parameter 
space. We assumed a range of T1,true = [1500 to 3000 ms] and initially set T2,true = 150 ms:  
 𝑇!,!"# 𝑇!,!"#$ = argmin!!∈!!,!"#$% 𝑆!"# 𝑇!,!"#$ ,𝐵!,!"#! ,𝑇!,!"#$ − 𝑆 𝑇!,!"# ,𝐵!,!"#! ,𝑇! ! ( 2 ) 
 
Minimizing the cost function yields the result for fitted T2  (“T2,fit”). The normalized 
difference between T2,fit and T2,true corresponds to the bias in the fitted T2  estimate due to 
using a fixed T1, which deviates from the true T1: 
 𝑇!𝑏𝑖𝑎𝑠 !!,!"# 𝑇!,!"#$ ,𝑇!,!"#$ =  𝑇!,!"# 𝑇!,!"#$ − 𝑇!,!"#$𝑇!,!"#$  ( 3 ) 
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This simulation was expanded for a range of T2,true values (T2,true = [50 to 250 ms]) to 
obtain the T2 bias over a range of T1,true and T2,true. Similarly, simulations were also 
performed to study the T2 bias due to relative B1+ variations over a range of 0.5 to 1.5.  
Phantom Study 
To verify our simulation results and to evaluate DESS-T2 mapping performance in the 
presence of T1 variations, we designed a phantom with 16 5-ml tubes filled with specific 
concentrations of Gd-DTPA and CuSO4 to adjust the T1 and T2 relaxation times. The 
tubes were placed in a container filled with water and arranged in a 4x4 grid to comprise 
a range of T1 values with variation along the column dimension and T2 along the row 
dimension in a parameter range typically observed in the prostate: T1 = 900 – 2000 ms, 
T2 = 100 – 300 ms. We acquired 3D DESS and for reference T2 mapping using 2D turbo 
spin echo with 9 TE values ranging from 12 to 270 ms. We also acquired a T1 map using 
an inversion recovery turbo spin echo (IR TSE) sequence with 9 IR times ranging from 
150 to 6000 ms to evaluate T1,true vs a global estimate T1,fix in the fitting algorithm. Other 
imaging parameters were identical to the volunteer study (Table 1). Quantitative T2 maps 
were calculated from DESS as described above and from TSE data using a simple 
exponential fit. Similarly, quantitative T1 was obtained from a simple exponential fit to 
the IR data. DESS T2 fits were obtained in two ways: 1) using a global estimate for T1,fix 
= 2200 ms and 2) using a voxel based T1 (T1,true) derived from the IR T1-map. For 
quantitative evaluation, ROIs were drawn in each tube. Median ROI values for DESS-T2 
were compared to TSE-T2. Further, DESS-T2 using T1,fix vs. a voxel-based T1 map was 
compared. For repeatability analysis a second DESS-T2 acquisition was obtained 90 
minutes later. 
Volunteer Study 
To evaluate prostate DESS T2 mapping in vivo, four healthy male volunteers (27 ± 4 
years) were scanned. To assess repeatability, three serial 3D DESS acquisitions (TA ~ 1 
min each) were acquired. For reference, 2D turbo spin echo (TSE)-T2 mapping was 
performed over a range of TE values (12 to 160 ms, total TA ~ 9 min). Detailed MR 
protocol parameters are listed in Table 1. Image analysis was performed in MATLAB. 
This is the author accepted manuscript version of Magn Reson Med 2016, DOI 10.1002/mrm.26053   
 
For quantitative data analysis, ROIs were drawn in prostate peripheral zone (PZ), 
transition zone (TZ) and muscle (M) on three consecutive central image slices. ROIs 
were drawn on DESS-T2 maps and copied to TSE-T2 maps. If necessary, i.e. if the 
volunteer shifted between DESS-T2 and TSE-T2 acquisitions, ROIs were manually 
adjusted in 2 out of 4 volunteers by 1-2 pixels on TSE-T2 to match DESS-T2 ROI 
location using anatomical landmarks. Combining ROI data from all four volunteers and 
three image slices resulted in a total of n = 12 ROIs per zone. Median ROI values were 
compared between DESS-T2 and TSE-T2. Repeatability was assessed on serial DESS-T2 
scans.  
Prostate Cancer Patient Study 
As a clinical proof-of-principle study, 29 consecutive patients (58 ±18 years) were 
prospectively scanned with DESS after urologist referral for prostate mp-MRI. Men with 
elevated serum prostate-specific antigen (PSA) were referred for lesion detection prior to 
biopsy, or active surveillance (in men with biopsy proven low-grade cancer). Patient 
scans were conducted between June 2014 and March 2015. After obtaining informed 
consent, patients were scanned using the clinical standard mp-MRI protocol, and the 
DESS-T2 mapping sequence was added (two serial 3D DESS scans, acquisition time for 
each scan was 1 min 3 s). In one patient, additionally, a high-resolution 3D DESS 
acquisition with image resolution matched to clinically acquired 3D T2w TSE was added 
to show the clinical potential of DESS to replace T2w-MRI.  Table 1 lists the detailed MR 
protocol parameters of sequences relevant for this study. As part of clinical routine in our 
institute, a board-certified, experienced radiologist (>2000 cases read) identified 
suspected cancerous lesions on multi-parametric MRI based on criteria employed at our 
institute for prostate MRI readings (21): For T2-w, ADC and DCE MRI, first an 
individual score for each of the three modalities ranging from 1-5 was assigned to a 
suspected MRI lesion (for scoring criteria see supporting Table S1). Finally, the overall 
suspicion level combining all three modalities was determined by the following formula: 
weighted average for final score = (2·ADC score + T2w score + DCE score)/4. If the 
combined score was 3 or greater, the lesion was termed “suspected cancerous lesion”. 
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 For quantitative analysis, suspected cancerous lesion (SL) ROIs were drawn on clinical 
protocol 3D T2-w TSE and re-drawn on DESS-T2 maps matching the spatial ROI shape 
and location using anatomical landmarks. In addition to the SL ROI, ROIs were also 
drawn in normal peripheral zone (PZ), transition zone (TZ) and muscle (M). Similar to 
healthy volunteers, repeatability of the DESS-T2 maps was also assessed by comparing 
serial DESS acquisitions. Further, to evaluate the dependence of DESS-T2 on T1 
variations, DESS-T2 obtained by using a fixed T1 estimate (T1,fix = 2200 ms (20)) in the 
fitting algorithm was compared to DESS-T2 using a pixel-based T1 map (calculated from 
variable flip angle (VFA) T1 mapping, MR protocol parameters see Table 1). 
An additional feature of the DESS acquisition is that by combining the quantitative T2-
map and the DESS-FID acquired image with appropriate weighting factors, “synthetic” 
T2-weighted images with any desired contrast weighting (TEeff) can be calculated: 
 𝐼!"!"" = 𝐼!"##!!"# ∙ 𝑒! !"!""!"##!!!  ( 4 ) 
Statistical Analysis 
All statistical analysis was performed in MATLAB. All ROI results are presented as 
median ± standard deviation. Pooling ROI results for all volunteers or patients together, 
the mean ± standard deviation from all median ROI values was used. Linear regression 
and Pearson’s correlation coefficient ρ was used to 1) compare DESS-T2 to reference T2 
mapping (TSE), 2) assess repeatability on serial DESS-T2 acquisitions and 3) evaluate the 
use of a global T1 vs. pixel-based T1 map. Differences between T2 values in different ROI 
zones were tested with one-way analysis of variance and zone pairs were compared in a 
multiple comparison test with Bonferroni correction. A p-value of < 0.05 was considered 
significant.  
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RESULTS  
Simulations 
Our simulations showed that DESS-T2 fitting using a global estimate for T1 and B1+ is 
robust in the presence of T1 and B1+ variations typically observed in prostate MRI. If the 
true T1 or B1+ is smaller (larger) than the global T1 or B1+ estimate, DESS-T2 is under- 
(over) estimated (Figure 2a, c). The bias in T2, due to T1 or B1+ variations is more severe 
for larger T2  (Figure 2b, d). However, results from a recent analysis of T1 and B1+ in a 
representative patient population showed that over the whole prostate, T1 variations were 
within 250 ms and B1+variations were within 10% (20). These observed parameter 
variations for T1 (B1+) would translate to a bias in DESS-T2 measurements of less than 
2% (5%) (indicated by a red box in Figure 2).  
Phantom Study 
Quantitative IR TSE-T1, TSE-T2 and DESS-T2 maps of the 4x4 T1/T2 phantom are shown 
in Figure 3 a-c. As intended by design, T1 in the tubes was approximately constant along 
rows, but varied along the column dimension and vice versa for T2. Assessing the T1 
dependence, phantom experiments confirmed our simulations results that using a fixed T1 
resulted in a bias in DESS-T2 estimates (if T1 true (from T1 map) < T1 fix (assumed) 
resulted in underestimation of DESS-T2). This bias was increased for larger T2 but within 
only a few percent over typical T1 variations (Figure 3d). ROI analysis showed that 
DESS-T2 was highly correlated to reference TSE-T2  (r2 = 0.99, p-value < 0.001) over a 
range of T1 values (Figure 3e). Repeatability for DESS-T2 in a scan-rescan experiment 
(after 90 min) was excellent (r2 = 0.99, p-value < 0.001) (Figure 3f). The coefficient of 
variation was slightly higher for DESS-T2 compared to TSE-T2, however the difference 
was not significant (p-value = 0.23). 
 
Volunteer Study 
3D DESS images in a healthy volunteer exhibited distinctly different image contrast in 
the FID and Echo images (Figure 4a, b). From these images quantitative 3D DESS-T2 
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maps were obtained (Figure 4c) and compared to reference 2D TSE-T2 maps (Figure 4d). 
ROI analysis yielded DESS-T2 of 115 ± 26 ms (mean ± SD of all volunteer ROI median 
values) in the PZ and 64 ± 7 ms in the TZ (Table 2, Figure 5a). A high correlation of 
DESS-T2 and TSE-T2  (r2  = 0.88, p-value < 0.001, Figure 5b) was found. However, 
DESS-T2 values were lower compared to TSE-T2 values. This can be explained by the 
fact that our TSE-T2 values were not corrected for contributions from stimulated echoes 
and achieving flip angles of less than 180° for the refocusing pulses in the multi-echo 
train. Both effects are known to result in T2 overestimation on multi-echo based SE T2 
mapping (10). A high correlation of DESS-T2 on serial scans (r2  = 0.95, p-value < 0.001, 
Figure 5c) indicated high repeatability. 
Prostate Cancer Patient Study 
In 29 scanned patients, 23 suspected cancerous lesions were identified on standard mp-
MRI in 17 patients. Only these men were included in further analysis. High-resolution 
DESS-Echo (Figure 6c) showed very similar T2w contrast compared to clinical standard 
T2w 2D TSE MRI (Figure 6b). DESS-FID and DESS-Echo images in patients showed 
clear depiction of morphological prostate zones, such as a distinction of PZ and TZ, on 
both contrast weightings (Figure 6c-f). These zones were also reflected in quantitative 
DESS-T2 maps (Figure 6g). Quantitative ROI analysis yielded DESS-T2 of 129 ± 39 ms 
(mean ± SD of all patient ROI median values) in the normal PZ and 83 ± 12 ms in the TZ 
(Table 2). DESS-T2 in SL (72 ± 14 ms) was significantly different from normal PZ (p < 
0.001, Figure 7a), but not from TZ T2. DESS-T2 on serial scans was highly correlated (r2  
= 0.79, p-value < 0.001, Figure 7b), even though the correlation was less than in healthy 
volunteers. We observed a very high correlation (r2  = 0.99, p-value < 0.001, Figure 7c) 
of DESS-T2 using a fixed T1 estimate (T1fix = 2200 ms) compared to DESS-T2 using a 
pixel-based T1-map. From the quantitative DESS-T2 map, we obtained flexible T2-w 
contrast by calculating “synthetic” T2-w images with TEeff = 100 ms (Figure 6h). 
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DISCUSSION 
Our results demonstrate that 3D quantitative T2 mapping can be performed rapidly in the 
entire prostate using DESS at 3T with a spatial resolution of 1.1 x 1.1 x 3.5 mm3 in about 
1 min. We found a high correlation between DESS-T2 and standard TSE-T2 mapping 
approaches. There is a clear advantage using DESS with regard to total acquisition time, 
since a conventional T2 mapping approach required about 9 min scan time. 
Quantitative in vivo mapping of T2 relaxation is still a challenge due to long scan 
durations. Multi-echo based T2 mapping (e.g., TSE) sequences are practical solutions to 
shorten the scan time, but they can be biased if stimulated echo contributions are not 
considered in the fitting algorithm and have considerably longer scan time than the DESS 
approach. Recently, acceleration techniques for multi-echo TSE have been proposed to 
reduce acquisition time three-fold from ~ 9 min to 2.8 min (22). Agarwal et al, combined 
k-t-T2 with partial Fourier MRI and SENSE reconstruction to achieve 7.9 fold 
acceleration to obtain 0.60 mm in-plane 2D T2 maps in a total acquisition time of 5 min 
55 s to cover the whole prostate (23).  For comparison, using 3D DESS to obtain the 
same image resolution would require 4 min 46 s without any acceleration techniques. 
Further, SAR is less of a concern for 3D DESS (FA=30°) compared to SE-type sequences, 
especially at 3 T.  
Even though in this study we found in simulations and in vivo, that the bias in DESS-T2 
estimates due to “normal” T1 variations over the prostate is small, this might not be the 
case for larger T1 variations, for example present in hematoma, i.e. bleeding after biopsy. 
However, this residual bias can be eliminated by using voxel-based T1 mapping, which is 
already part of clinical mp-MRI protocols because of its key role for quantitative DCE 
data analysis. 
The prostate can be divided into different anatomical zones, which exhibit distinct tissue 
properties (24). The noncancerous, noninflamed  peripheral zone is characterized by high 
macromolecular and free water content in luminal space, leading to longer T2. 
Noncancerous central gland, including the transition zone has often a more heterogeneous 
appearance, especially when involved by benign prostatic hyperplasia, with overall 
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shorter T2. This is reflected in our study results. We observed longer T2 in the PZ as 
compared to the TZ for volunteers and patients using DESS-T2. Further, our results using 
DESS-T2  (129 ± 39 / 83 ± 12 ms in patient PZ and TZ) were in the same range as 
previously published T2 values using TSE-T2 mapping approaches at 3T (6,7,23,25,26). 
In addition, our result for muscle DESS-T2  (38 ± 4 ms) compares well to muscle T2 
measured by Stanisz et al (40 ± 4 ms) at 3T (27). Cancerous tissue consists of highly 
compacted cells resulting in decrease in T2. We found a significantly lower DESS-T2 in 
suspected cancerous lesions (72 ± 14 ms) as compared to normal PZ tissue. Similarly, 
decreased T2 in lesions was previously observed using spin echo mapping approaches 
(6,7,23,26). However, as it was recently pointed out by Langer et al. (28), although T2 
may help distinguish dense tumors from normal PZ tissue, bulk T2 of sparse tumors 
(defined as intermixed prostate cancer with normal tissue) may not be significantly 
different from surrounding normal tissue. Therefore, the presence of normal PZ 
components in prostate cancer places inherent limitations on the ability of T2 (and 
similarly to ADC within the mp-MRI protocol) to fully characterize PZ tumors.  
The consensus for clinical prostate MRI interpretation recommends reviewing multi-
parametric images in conjunction, including T2-w, diffusion and dynamic contrast 
enhanced T1-w images (29). The diagnostic performance of this multi-parametric 
approach may be potentially improved by the addition of a quantitative T2 map. If done 
correctly, quantitative imaging yields a direct and repeatable assessment of tissue 
properties. The apparent diffusion coefficient (ADC) obtained from diffusion weighted 
imaging already adds a quantitative parameter to most clinical prostate MRI protocols 
and has been proven to be of great value in clinical prostate MRI (7,8,30–32). 
Quantitative T2 may further enhance conventional multi-parametric quantitative analysis. 
Recent studies showed that quantitative T2, similar to quantitative ADC, negatively 
correlated to cell density (12), however to a lesser extent as ADC. Therefore quantitative 
T2 may facilitate noninvasive assessment of prostate cancer aggressiveness. For example, 
Wang et al found a correlation between signal intensity on T2-w images with Gleason 
grade at whole mount pathologic evaluation after radical prostatectomy (33). 
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Even though the primary objective of this study was to present quantitative T2 mapping, 
to be clinically relevant, the presented 3D DESS sequence must have potential to replace 
current T2w imaging in the standard clinical protocol. This has already been 
demonstrated in an early study at 1.5 T (34). Also in our study, the “Echo” image showed 
similar contrast to current T2w imaging. Further, using the DESS approach, any desired 
T2 weighted image contrast can be retrospectively reconstructed using the quantitative 
DESS-T2 map. A potential application of a “tunable” T2 contrast image might be in post-
processing algorithms such as automatic segmentation of the prostate as is required for 
studies comparing imaging results to whole-mount specimen analysis after prostatectomy.  
Our study had several limitations. First, we only considered a single T2 component in our 
analysis. However, recent studies have shown that prostate tissue in healthy volunteers 
can exhibit at least two T2 components (35,36). DESS-T2 mapping can be extended to a 
multi-component T2 analysis if multiple DESS acquisitions, are acquired, thereby 
yielding more than two DESS-images for data fitting. Second, in our study we found 
significantly different T2 in suspected cancerous lesion compared to PZ T2. This might be 
important since most cancers are found in the PZ. On the other hand, we did not observe 
a significantly different mean T2 in lesion compared to T2 in the TZ. However, our patient 
population was small, potentially too small to lead to significant differences. Wang et al 
(33) found that lesions in the TZ classified as Gleason grade 3 had a significantly lower 
T2 w signal intensity ratio than did lesions in the PZ classified as the same Gleason grade. 
As noted above, TZ prostate tissue appears more heterogeneous which potentially might 
hinder lesion detection based on quantitative imaging. Third, an important limitation of 
the DESS approach is the motion sensitivity of the acquisition sequence. This especially 
affects the “Echo” signal, which is lower in SNR. Our patients received Glucagon 
injection to reduce bowel movement. DESS T2 -mapping could potentially greatly benefit 
from motion correction techniques. Finally, we did not correlate our quantitative T2 
results to histopathology or clinical outcome in this proof-of-principle patient study. This 
needs to be a topic of future research in large-scale patient studies, which could be 
accomplished using the fast 3D DESS T2 mapping sequence as an add-on to standard 
prostate mp-MRI. 
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CONCLUSION 
In conclusion, we have demonstrated that rapid one-minute 3D T2 mapping of the entire 
prostate can be performed using DESS at 3T. Our results showed that DESS-T2 was not 
sensitive to T1, B1+ in a range typically observed in the prostate and has excellent 
repeatability. In an initial proof-of-principle patient study we have shown that DESS-T2 
in suspected cancerous lesions was significantly lower than in normal peripheral zone 
tissue. Based on our technique, the potential clinical impact of quantitative T2 needs 
validation in further large-scale patient studies with multi-reader analysis and cross 
validation to histopathologic Gleason score and clinical outcomes.  
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FIGURES 
 
 
Figure 1.  The DESS pulse sequence is a steady-state gradient echo sequence. In each TR 
two echoes with distinct image contrast are acquired, called the “FID" and the “Echo". A 
small spoiler gradient is applied between the FID and Echo signal to suppress banding 
artifacts. 
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Figure 2: Simulations show that using a fixed T1 estimate (T1,fix = 2200 ms) in the data 
fitting routine results in T2 under- (over-) estimation (T2,true = 150 ms), if the true T1 is 
lower (higher) than the T1 estimate (a). If the true T1 deviates from the T1 estimate, the 
bias observed in the fitted T2 -values is larger for increasing T2  (b). Similar observations 
hold for B1+ variations (c,d). The simulated bias is within 2% (5%) for variations in T1 
(B1+) typically observed in the prostate (red box). 
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Figure 3: A phantom with T1 / T2 variations primarily along columns / rows was imaged 
using 2D Inversion Recovery (IR) turbo spin echo (TSE) T1 mapping (a), 2D TSE-T2 
mapping (b) and 3D DESS-T2 mapping (c). Using a fixed T1 estimate (T1 = 2200 ms) in 
the fitting routine, deviations in fitted T2 values were found that were increased for larger 
T2, consistent with simulation results (d). DESS-T2 measurements were highly correlated 
with TSE-T2 (r2 = 0.98) over a range of T1 values, using the T1 map in the fitting routine 
(e). Scan-scan DESS-T2 measurements showed excellent repeatability (f). The coefficient 
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of variation (CV) was higher for DESS-T2 compared to TSE-T2, however the difference 
was not significant (p-value = 0.23) (g).  
 
Figure 4: Representative DESS images from a healthy volunteer are shown: DESS-FID 
(a), DESS-Echo (b), DESS-T2 map (c) and for comparison a TSE-T2 map (d). DESS-FID 
and DESS-Echo are displayed at same window level settings. ROIs were drawn for 
further quantitative data analysis as shown in (a) in the peripheral zone (PZ), transition 
zone (TZ) and in muscle (M). 
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Figure 5: Results of quantitative analysis in healthy volunteers. Median T2 values for the 
different ROI zones are shown for TSE-T2 and 3 consecutive DESS-T2 measurements 
(scan #1 to #3) (a). DESS-T2 in all zones was significantly different from each other (p-
value < 0.001), with larger DESS-T2 in the PZ as compared to TZ. DESS-T2 values (scan 
#1) were highly correlated with TSE-T2 measurements (r2 = 0.88, p-value < 0.001). 
Correlation of T2 measurements obtained by two sequential DESS acquisitions was high 
(r2 = 0.95, p-value < 0.001). 
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Figure 6: Representative DESS images from a prostate cancer patient compared to 
clinical standard T2-w MRI: 3D T2w TSE (a) and 2D-TSE T2w (b) showed very similar 
T2w contrast as high-resolution (0.66x0.66x1.5mm3) 3D DESS-Echo (c). Simultaneously 
acquired high-resolution 3D DESS-FID (d) provided one additional contrast image. For 
T2-mapping, low-resolution (1.1x1.1x3.5 mm3) 3D DESS-Echo (e) and DESS-FID (f) 
was fitted to obtain 3D DESS-T2 map (g). DESS-FID and DESS-Echo are displayed at 
same window level settings. Retrospectively, using the DESS-T2 map and the DESS-FID, 
3D T2-w images with desired “effective" TE contrast can be generated: e.g. TEeff = 100 
ms (h). A suspected cancerous lesion (indicated by a yellow arrow) identified by a 
radiologist on the clinical T2-w images (a and b) is visually apparent in DESS images (c-
h) and has low T2-values (g). Note that a water excitation only pulse was used in low-
resolution DESS (e,f) for fat suppression. For imaging parameters see Table 1. 
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Figure 7: Results of quantitative analysis in prostate cancer patients. Median T2 in SL 
ROIs was significantly different from PZ ROIs (p < 0.001) and but not from ROIs in the 
TZ (a). ROI T2 values in repeated DESS scans were correlated (r2  = 0.79, p-value < 
0.001 (b)). There were no significant differences in T2 if using a fixed T1 estimate (2200 
ms) or a pixel-based T1 map (r2  = 0.99, p-value < 0.001 (c)). 
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TABLES 
Table 1: MR protocol parameters. 
Study 
Patient, 
Volunteer 
and 
Phantom: 
3D DESS 
Patient: 
high-
resolutionb 
3D DESS 
Patient: 
2D T2 w 
imaging 
Patient: 
3D T2w 
imaging 
Phantom 
and 
Volunteer: 
2D T2 
mapping 
Patient 
and 
Volunteer: 
T1 
mapping 
Phantom: 
T1 
mapping 
Sequence DESS
a 
(low-res) 
DESS 
(high-res) T2w -TSE 
3D T2w-
TSE T2 –TSE
c T1-VIBE-Dixond 
T1 –TSEe 
Acquisitio
n  3D 3D 2D 3D 2D 3D 2D 
Fat 
Suppressio
n 
Water 
Excitation 
only 
      
Inversion 
Recovery 
Time 
      variablee 
FOV 
[mm2] 220x220 170x170 200x200 170x170 220x220 260x260 220x220 
Image 
Matrix 192x192 256x256 310x320 256x256 192x192 160x160 192x192 
Resolution
[mmxmm] 1.1x1.1
f 0.66 x 0.66g 0.6x0.6 
0.66 x 
0.66g 1.1x1.1 1.6x1.6 1.1x1.1 
# PE Lines 287h 461h 651h 328h 
192 
(phantom), 
308h 
(volunteer) 
207h 192  
Parallel 
Imaging 
(R) 
2 2 - 2 - - - 
Slice 
Thickness 
[mm] 
3.5f 1.5g 3.6 1.5g 3.5 3.6 3.5 
TR [ms] 18.56 19 4000 2200 4000 4.17 10500 
TE [ms] 4.16 5 101 201 variablec 2.46 12 
Flip Angle 
[°] 30 30 160 110 180 variable
d 180 
# 
Averages 1 2 2 2 1 3 1 
Echo 
Train 
Length 
- - 25 - 22 2 22 
Bandwidth 
[Hz/px] 160 160 200 315 130 895 130 
Acquisitio
n Time 
[min: sec] 
1:03 7:26 3:20 7:00 
0:31 
(phantom), 
1:02 
(volunteer) 
0:35 1:24 
aDESS was acquired 3x (2x) in volunteers (patients) to assess repeatability. 
bThe resolution and FOV coverage of the high-resolution 3D DESS acquisitions were 
matched to clinically acquired 3D T2w TSE. 
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cT2-TSE method for T2 mapping: Sequence was repeated 9 times with TEs of [12, 25, 37, 
61, 74, 09, 111, 135, 160] ms, total time ~ 9 min 
dVariable Flip Angle (VFA) method for T1 mapping: Sequence was repeated 4 times with 
a flip angle of 2°, 5°, 10° and 15° 
eInversion Recovery (IR)-TSE method for T1 mapping: Sequence was repeated 9 times 
with inversion times of [50, 100, 150, 300, 500, 1000, 2000, 4000, 6000] ms 
fFor low resolution DESS, this is the acquired, raw image resolution, no interpolation. 
gFor high resolution DESS, matched to 3D T2-w imaging, this is the interpolated 
resolution (0.66 x 0.66 x 1.50 mm3); the acquired resolution was (0.74 x 0.66 x 2.25 
mm3) 
h Oversampling along phase-encode (right-left) dimension to avoid fold-over artifacts 
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Table 2: Quantitative DESS-T2 values in healthy volunteers and patients (Median ± SD).  
ROI zonea  SL PZ TZ M 
Volunteerb TSE-T2 [ms]  138 ± 23 92 ± 11 49 ± 5 
 DESS-T2 [ms]  115 ± 26 64 ± 7 37 ± 2 
Patientc DESS-T2 [ms] 72 ± 14 129 ± 39 83 ± 12 38 ± 4 
a For ROI location see Figure 4 and 6, SL = suspected cancerous lesion, PZ = peripheral 
zone, TZ = transition zone, M = muscle 
b12 ROIs were analyzed in healthy volunteers (n = 4, 3 image slices each) 
c23 ROIs were analyzed in prostate cancer patients (n = 17 patients, 1 slice per lesion) 
 
 
 
  
This is the author accepted manuscript version of Magn Reson Med 2016, DOI 10.1002/mrm.26053   
 
SUPPORTING MATERIAL  
Supporting Table S1: 
Score T2-w TSE ADC (x 10-
3mm2/s) 
DCE 
1 Normal > 1.4 Normal 
2 Faintly decreased signal 1.2 – 1.4 Early or intense enhancement 
3 Distinct low signal 1.0 – 1.2 Early and intense enhancement or 
early enhancement with washout 
4 Distinct low signal with 
ill-defined margins 
0.8 – 1.0  Early and intense enhancement with 
washout 
5 Focal low signal with 
mass effect 
< 0.8  Early enhancement is intense with 
immediate washout 
 
Scoring criteria (1) for multi-parametric prostate MRI at our institution: T2-weighted 
turbo spin echo (T2-w TSE), apparent diffusion coefficient (ADC) mapping, dynamic 
contrast enhanced (DCE) MRI. First an individual score for each of the three modalities 
ranging from 1-5 was assigned to a suspected MRI lesion. The overall suspicion level 
combining all three modalities was determined by the following formula: weighted 
average for final score = (2·ADC score + T2w score + DCE score – TZ)/4 where “TZ” is 
1 if the lesion lies in the transition zone and 0 otherwise. If the combined score was 3 or 
greater the lesion was termed “suspected cancerous lesion” and included in study. 
 
